Pharmacological effect of ZYGK1, a novel glucokinase activator, in hyperglycemic and sulfonylurea-resistant type 2 diabetes in mice models

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 914e84ce3e1b7e2d-LAX IP: 116.62.10.13 UTC time: 2025-02-20T12:32:20+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4